Navigation Links
Gene therapy increases survival for end-stage head and neck cancer
Date:5/28/2008

ctively in the phase III trial, with results related to biomarker status blinded until final data analysis.

If a tumor expresses high or low levels of normal p53, or a very low level of mutant p53, conditions are favorable for Advexin. Tumors with high levels of mutant p53 do not respond well to p53-related therapy. The healthy and mutant p53 biomarkers are easily discerned with standard lab techniques, Roth said immunohistochemical staining detects protein levels, while gene chip analysis reveals gene sequence.

Creation of Introgen

Roth found little interest in gene therapy from established pharmaceutical companies, so in 1994 he co-founded Introgen working through M. D. Anderson's Office of Technology Management.

Introgen has since grown into a publicly traded company on NASDAQ, and while it still licenses important technology from M. D. Anderson, the company works broadly with other medical research institutions and biotech firms.

Introgen developed a commercial-grade version of the drug and advanced it through phase II and III clinical trials for head and neck cancer. Advexin(r) also is being tested in other cancers in a variety of clinical trials.

"If something's going to get to patients, it has to be commercialized," Roth said. The National Cancer Institute funds basic and translational research but simply cannot afford to fund large, late-stage clinical trials, he said.

Nanotechnology and p53

Roth and colleagues now focus on ways to deliver p53 and other tumor-suppressing genes systemically - through intravenous delivery. Advexin has to be injected straight into the tumor, but that's not workable for many cancers. Head and neck cancer kills patients by recurring, not spreading to other organs, but most cancer deaths involve metastasis.

By wrapping tumor-suppressing genes in tiny balls of fat, Roth and colleagues hope to be able to treat more invasive cancers. Whil
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. HIV therapy in pregnancy-data support WHO recommendations
3. Family-based treatment more effective than supportive psychotherapy in treating bulimia
4. Trial to Test Gene Therapy for Angina in Women
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
9. New Drug No Substitute for Standard Blood-Clot Therapy
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene therapy increases survival for end-stage head and neck cancer
(Date:9/3/2015)... ... September 03, 2015 , ... The first part of a ... made by IVC filter lawsuits filed against Bard.** These lawsuits, filed by ... Bard IVC filter broke or failed, have recently been consolidated for pretrial proceedings as ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... eating disorder treatment for adults and adolescents struggling with anorexia, bulimia, binge ... joined the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu collaborates ...
(Date:9/3/2015)... CANADA (PRWEB) , ... September 03, 2015 , ... ... today announced that it will be spotlighting its award-winning print and artwork inspection solutions, ... Vision team September 16 and 17 at the Olympia London, booth #F33 , Be ...
(Date:9/3/2015)... ... September 03, 2015 , ... Hunters Creek Retrievers is again ... champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 ... to enjoy Thanksgiving and Christmas with an extra big smile. , This adorable ...
(Date:9/3/2015)... ... ... A scar is an unavoidable result of incision or injury to the skin. Unsightly as ... itself. The appearance of a scar is dependent on many factors – the size and ... scars fade to near invisibility on their own over a period of months,” says ...
Breaking Medicine News(10 mins):Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4
... , WINSTON-SALEM, N.C., Sept. 11 Sales ... and three years after the FDA approved the drug an estimated ... on advertising and lobbying for government mandates. A recent marketing ... assistant professor of marketing at Wake Forest University, and several colleagues ...
... , , TERRE HAUTE, Ind., Sept. ... has one of the school,s environmental health sciences professors using the campus ... who is entering her second year at the school, is teaching the ... The course challenges students to learn about various types of pathogens ...
... , WASHINGTON, Sept. 11 On Tuesday, September 15, the ... major national Islamic organizations, will host a Capitol Hill citizens, hearing on ... DATE: Tuesday, September 15, 2009 , , PLACE: Rayburn ... TIME: 10 AM-1 PM (Social Hour 10-11 AM, Presentations 11 AM-12:30 ...
... SEATTLE, Sept. 11 The following blog post was published September 4, ... of the 2008 Weblog award for best new blog, and Time.com,s 25 ... the devil is in the details, but if you get so focused ... create, then whatever you,re doing, however well the "process" worked, and however ...
... thinner arms and legs as they get older? As we age ... which decreases strength and increases the likelihood of falls and fractures. ... do about it. A team of Nottingham researchers has already ... fast as the young. Now they,ve found that the suppression of ...
... HILL, N.J., Sept. 11 Nuvilex, Inc. (OTC Bulletin ... joint venture partner, has informed the company that Reme-Flu(TM) ... homeopathic remedy for helping to prevent and treat flu-like ... Reme-Flu(TM) formula consists of a two-part protocol. Part ...
Cached Medicine News:Health News:HPV Vaccine Study Shows Why Few Women Getting Shots 2Health News:Professor Uses H1N1 as a Teaching Tool 2Health News:Professor Uses H1N1 as a Teaching Tool 3Health News:Muslim Coalition to Host D.C. Hearing on Health Care Reform 2Health News:Muscle: 'Hard to build, easy to lose' as you age 2Health News:Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula 2Health News:Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula 3
(Date:9/3/2015)... , Sep. 03, 2015 ... the addition of the "Diabetes Care Devices Market ... (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, ... to 2020" report to their offering. ... be valued at USD 1.7 Billion in 2015 and ...
(Date:9/3/2015)... N.Y. , Sept. 3, 2015  VirtualScopics, ... of clinical trial imaging solutions, announced today, they ... support for a new philanthropic, epidemiology study partnering ... Africa .  VirtualScopics has teamed up with ... in Zambia.  The image results will be used ...
(Date:9/3/2015)... -- The findings of a year-long investigation conducted by NBC ... handling of its Recovery IVC filter product ... part one of the series revealed that ... fatalities, have been associated with the Recovery device. NBC ... Bard in 2004 which linked the Recovery IVC filter ...
Breaking Medicine Technology:The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3
... ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var ...
... Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia,... -- BOZEN, Sud-Tirol, Italy, October ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; ...
Cached Medicine Technology:Warner Chilcott Announces FDA Approval of Next Generation Actonel 2Warner Chilcott Announces FDA Approval of Next Generation Actonel 3Warner Chilcott Announces FDA Approval of Next Generation Actonel 4Warner Chilcott Announces FDA Approval of Next Generation Actonel 5Warner Chilcott Announces FDA Approval of Next Generation Actonel 6Warner Chilcott Announces FDA Approval of Next Generation Actonel 7Warner Chilcott Announces FDA Approval of Next Generation Actonel 8Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 2Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 3Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 4Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 5Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 6Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 7Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia 8
Single Use Loading Units with Titanium Staplers for use with MULTIFIRE ENDO TA™ 30 12 mm (Single Use Staplers with Titanium Staplers)....
Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Single Use Loading Units (SULU's) with Titanium Staples for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Providing maximum versatility and maneuverability, the Articulator 35 is the only stapler for use in endoscopic and open procures that provides greater access to targeted structures with limited oper...
Medicine Products: